Arterial oxygen pressure targets in critically ill patients: Analysis of a large ICU database

Chang Xu,Dan-Wei Jiang,Wei-Yong Qiu,Yan-Xue Zhou,Long-Wang Chen,Guang-Liang Hong,Guang-Ju Zhao,Zhong-Qiu Lu,Dan-wei Jiang,Wei-yong Qiu,Yan-xue Zhou,Long-wang Chen,Guang-liang Hong,Guang-ju Zhao,Zhong-qiu Lu
DOI: https://doi.org/10.1016/j.hrtlng.2020.10.015
2021-01-01
Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Background</h3><p>Providing supplemental oxygen is common in the management of critically ill patients, yet the optimal oxygen regimen remains unclear.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Objectives</h3><p>To explore the optimal range of PaO<sub>2</sub> in critically ill patients.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>This is a retrospective study conducted in the Medical Information Mart for Intensive Care III (MIMIC-III) database. The patients with a least 48 h of oxygen therapy were included. Nonlinear regression was used to analyze the association between PaO<sub>2</sub> and mortality. We derived an optimal range of PaO<sub>2</sub> and evaluated the association between the proportion of PaO<sub>2</sub> measurements within this range and mortality.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>In total, 8401 patients were included in the study. A J-shaped relationship was observed between median PaO<sub>2</sub> and hospital mortality. Compared with the reference group of 100–120 mmHg, patients with values of 80–100 mmHg and 120–140 mmHg had higher hospital mortality (adjusted odds ratio [aOR], 1.23; 95% CI, 1.05–1.43 and 1.29; 95%CI, 1.08–1.54, respectively). Similarly, mortality rates were significantly higher for PaO<sub>2</sub> &lt;80 mmHg and ≥140 mmHg (aOR, 1.97; 95%CI, 1.58–2.45 and 1.42; 95%CI, 1.19–1.69, respectively). Patients spent a greater proportion of time within 100–120 mmHg tended to have a lower mortality rate.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusion</h3><p>Among critically ill patients, the relationship between median PaO<sub>2</sub> and hospital mortality was J-shaped. The lowest rates of mortality was observed in those with PaO<sub>2</sub> levels within 100 to 120 mmHg.</p>
nursing,cardiac & cardiovascular systems,respiratory system
What problem does this paper attempt to address?
The problem that this paper attempts to solve is: in the intensive care unit (ICU), for critically ill patients requiring oxygen therapy, what is the optimal partial pressure of arterial oxygen (PaO₂) target range. Specifically, the study aims to evaluate the relationship between PaO₂ and hospital mortality, and through analysis, determine an optimal oxygen therapy target range applicable to the ICU. ### Research Background Supplying supplemental oxygen is a common practice in managing critically ill patients, but the optimal oxygen therapy regimen remains unclear. Although the harm of hypoxemia has been fully recognized and actively avoided, hyperoxemia is generally accepted. However, recent studies have shown that in some cases, such as septic shock, ST - segment elevation myocardial infarction, and critically ill ICU patients, hyperoxemia may be associated with adverse outcomes. Therefore, determining the optimal PaO₂ target range for critically ill patients is of great significance. ### Research Objectives 1. **Explore the optimal PaO₂ range for critically ill patients**: By analyzing the relationship between PaO₂ and mortality, determine an optimal PaO₂ range. 2. **Evaluate the relationship between the proportion of time within the optimal PaO₂ range and mortality**: Investigate whether the proportion of time that patients are within the optimal PaO₂ range is associated with lower mortality. ### Methods - **Data Source**: Use data from the MIMIC - III database, which contains clinical data of more than 40,000 ICU patients. - **Research Subjects**: The inclusion criteria were patients aged over 16 years and who received at least 12 days of oxygen therapy during their ICU stay. - **Statistical Analysis**: Use the generalized additive model (GAM) to analyze the nonlinear relationship between PaO₂ and mortality, and adjust for confounding factors through a multivariate logistic regression model. ### Results - **Overall Results**: A total of 8,401 patients were included, and the overall hospital mortality rate was 22.8%. - **Relationship between PaO₂ and Mortality**: A J - shaped relationship was observed between PaO₂ and hospital mortality, that is, both too low and too high PaO₂ were associated with higher mortality. The optimal PaO₂ range was 100 - 120 mmHg, and patients within this range had the lowest mortality rate. - **Specific Data**: - PaO₂ < 80 mmHg: Mortality rate was 32.5% - PaO₂ 80 - 100 mmHg: Mortality rate was 23.9% - PaO₂ 100 - 120 mmHg: Mortality rate was 20.1% (reference group) - PaO₂ 120 - 140 mmHg: Mortality rate was 22.2% - PaO₂ ≥ 140 mmHg: Mortality rate was 21.1% ### Conclusions Among critically ill patients requiring oxygen therapy, there is a J - shaped relationship between PaO₂ and hospital mortality, and the optimal PaO₂ range is 100 - 120 mmHg. Mild arterial hyperoxemia (PaO₂ 100 - 120 mmHg) may be associated with lower mortality. However, these results still need further interventional studies to confirm. ### Important Formulas - **Adjusted Odds Ratio (aOR)**: \[ \text{aOR}=\frac{\text{Mortality rate in the exposed group}}{\text{Mortality rate in the non - exposed group}} \] For example, the aOR for PaO₂ 80 - 100 mmHg is 1.23 (95% CI: 1.05 - 1.43), indicating that compared with the reference group (100 - 120 mmHg), the death risk of patients with PaO₂ 80 - 100 mmHg is increased by 1.23 times. ### Limitations - **Retrospective Design**: There may be selection bias. - **Single - center Study**: The generalizability of the results is limited. - **Lack of Data on Patients Who Did Not Receive Oxygen Therapy**. - **Oxygen Therapy Specific Methods Not Fully Explored**. ### Future Directions More interventional studies are needed to verify these results and explore the optimal PaO₂ target ranges for different disease subgroups.